| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peptidoglycan | 11 | 2021 | 47 | 3.790 |
Why?
|
| Bacillus anthracis | 19 | 2021 | 153 | 3.440 |
Why?
|
| Receptors, IgG | 24 | 2013 | 47 | 3.060 |
Why?
|
| Phosphoric Monoester Hydrolases | 22 | 2010 | 48 | 2.680 |
Why?
|
| B-Lymphocytes | 28 | 2010 | 285 | 2.630 |
Why?
|
| Monocytes | 10 | 2019 | 135 | 2.020 |
Why?
|
| Anthrax | 10 | 2021 | 91 | 1.970 |
Why?
|
| Signal Transduction | 44 | 2019 | 1469 | 1.900 |
Why?
|
| Immunity, Innate | 11 | 2018 | 231 | 1.620 |
Why?
|
| Blood Coagulation | 3 | 2019 | 120 | 1.480 |
Why?
|
| Sepsis | 4 | 2021 | 86 | 1.300 |
Why?
|
| Receptors, Antigen, B-Cell | 13 | 2009 | 35 | 1.240 |
Why?
|
| Inflammation Mediators | 3 | 2019 | 169 | 1.160 |
Why?
|
| Phagocytosis | 8 | 2013 | 80 | 1.110 |
Why?
|
| Cytokines | 9 | 2019 | 451 | 1.050 |
Why?
|
| Interleukin-6 | 5 | 2014 | 198 | 1.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 10 | 2010 | 163 | 0.980 |
Why?
|
| Immunoglobulin G | 4 | 2018 | 272 | 0.910 |
Why?
|
| T-Lymphocytes | 19 | 2009 | 285 | 0.890 |
Why?
|
| Proto-Oncogene Proteins | 13 | 2010 | 140 | 0.880 |
Why?
|
| Mice | 45 | 2018 | 4802 | 0.860 |
Why?
|
| Animals | 62 | 2021 | 10684 | 0.840 |
Why?
|
| Antigens, CD | 10 | 2006 | 140 | 0.830 |
Why?
|
| Complement System Proteins | 2 | 2014 | 24 | 0.830 |
Why?
|
| Proto-Oncogene Proteins c-vav | 9 | 2009 | 14 | 0.790 |
Why?
|
| src-Family Kinases | 12 | 2010 | 71 | 0.780 |
Why?
|
| Disseminated Intravascular Coagulation | 3 | 2018 | 16 | 0.780 |
Why?
|
| src Homology Domains | 14 | 2010 | 31 | 0.770 |
Why?
|
| Phosphorylation | 35 | 2010 | 585 | 0.750 |
Why?
|
| Lymphopoiesis | 3 | 2009 | 22 | 0.730 |
Why?
|
| rac GTP-Binding Proteins | 7 | 2009 | 12 | 0.720 |
Why?
|
| Phosphatidylinositol 3-Kinases | 14 | 2010 | 135 | 0.720 |
Why?
|
| Staphylococcus aureus | 3 | 2018 | 121 | 0.700 |
Why?
|
| Serum Amyloid P-Component | 2 | 2018 | 9 | 0.670 |
Why?
|
| Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 19 | 2010 | 22 | 0.670 |
Why?
|
| Lymphocyte Activation | 17 | 2002 | 210 | 0.650 |
Why?
|
| Protein-Tyrosine Kinases | 17 | 2010 | 97 | 0.650 |
Why?
|
| Mice, Knockout | 14 | 2014 | 874 | 0.630 |
Why?
|
| Endocytosis | 2 | 2009 | 96 | 0.600 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 3 | 2009 | 31 | 0.590 |
Why?
|
| Cell Cycle Proteins | 7 | 2005 | 187 | 0.580 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2018 | 34 | 0.550 |
Why?
|
| Myeloid Cells | 3 | 2009 | 27 | 0.550 |
Why?
|
| Tyrosine | 13 | 2001 | 92 | 0.550 |
Why?
|
| Macrophages | 5 | 2010 | 305 | 0.540 |
Why?
|
| Respiratory Tract Infections | 3 | 2018 | 37 | 0.530 |
Why?
|
| Neutrophils | 5 | 2018 | 183 | 0.520 |
Why?
|
| Protein Tyrosine Phosphatases | 7 | 2002 | 38 | 0.510 |
Why?
|
| Cell Line | 23 | 2016 | 700 | 0.470 |
Why?
|
| Humans | 66 | 2019 | 28851 | 0.470 |
Why?
|
| Receptors, Immunologic | 6 | 2016 | 73 | 0.450 |
Why?
|
| ras Proteins | 6 | 2002 | 43 | 0.440 |
Why?
|
| Proteins | 11 | 2002 | 254 | 0.430 |
Why?
|
| Blood Cells | 3 | 2002 | 10 | 0.420 |
Why?
|
| Enzyme Precursors | 6 | 2002 | 16 | 0.410 |
Why?
|
| Platelet Activation | 3 | 2013 | 54 | 0.410 |
Why?
|
| Lysosomes | 2 | 2011 | 56 | 0.400 |
Why?
|
| Dynamins | 2 | 2009 | 8 | 0.390 |
Why?
|
| Neuropeptides | 2 | 2009 | 27 | 0.390 |
Why?
|
| Isoenzymes | 8 | 2002 | 88 | 0.370 |
Why?
|
| Antigen Presentation | 2 | 2009 | 82 | 0.370 |
Why?
|
| Down-Regulation | 4 | 2002 | 202 | 0.360 |
Why?
|
| Antibodies, Bacterial | 1 | 2012 | 103 | 0.360 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 6 | 1997 | 62 | 0.360 |
Why?
|
| Antibody Formation | 2 | 2010 | 77 | 0.360 |
Why?
|
| Cells, Cultured | 13 | 2013 | 1022 | 0.350 |
Why?
|
| Lung | 6 | 2016 | 382 | 0.350 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 13 | 2004 | 285 | 0.350 |
Why?
|
| Enzyme Activation | 15 | 2010 | 267 | 0.340 |
Why?
|
| Mitogen-Activated Protein Kinases | 5 | 2006 | 88 | 0.330 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2010 | 45 | 0.330 |
Why?
|
| Type C Phospholipases | 9 | 2002 | 31 | 0.330 |
Why?
|
| Myelopoiesis | 1 | 2010 | 10 | 0.320 |
Why?
|
| Bacterial Toxins | 4 | 2016 | 273 | 0.320 |
Why?
|
| Spores, Bacterial | 5 | 2018 | 49 | 0.310 |
Why?
|
| Mice, Inbred C57BL | 11 | 2016 | 1653 | 0.310 |
Why?
|
| Phagosomes | 1 | 2009 | 6 | 0.300 |
Why?
|
| Nuclear Proteins | 2 | 2009 | 249 | 0.300 |
Why?
|
| MAP Kinase Signaling System | 2 | 2008 | 95 | 0.290 |
Why?
|
| Papio | 3 | 2021 | 81 | 0.290 |
Why?
|
| GRB2 Adaptor Protein | 8 | 2009 | 11 | 0.290 |
Why?
|
| Flow Cytometry | 6 | 2019 | 292 | 0.280 |
Why?
|
| DNA-Binding Proteins | 3 | 2009 | 490 | 0.280 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 1507 | 0.270 |
Why?
|
| Membrane Glycoproteins | 5 | 2010 | 149 | 0.270 |
Why?
|
| Antigens, Bacterial | 3 | 2016 | 165 | 0.270 |
Why?
|
| Lymphocytes | 3 | 2014 | 90 | 0.270 |
Why?
|
| Protein Binding | 8 | 2013 | 667 | 0.260 |
Why?
|
| Phosphotyrosine | 10 | 2002 | 18 | 0.260 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 6 | 2002 | 14 | 0.250 |
Why?
|
| Macrophages, Alveolar | 5 | 2010 | 36 | 0.250 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2014 | 994 | 0.240 |
Why?
|
| fas Receptor | 4 | 2003 | 19 | 0.240 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 3 | 2002 | 51 | 0.240 |
Why?
|
| Alveolar Epithelial Cells | 2 | 2018 | 15 | 0.240 |
Why?
|
| Apoptosis | 5 | 2003 | 780 | 0.240 |
Why?
|
| Amino Acid Motifs | 5 | 2002 | 66 | 0.230 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2005 | 9 | 0.230 |
Why?
|
| Chemotaxis | 1 | 2005 | 28 | 0.230 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2019 | 82 | 0.220 |
Why?
|
| Hydrolysis | 7 | 2011 | 60 | 0.210 |
Why?
|
| Models, Biological | 10 | 2016 | 469 | 0.210 |
Why?
|
| Cell Wall | 2 | 2021 | 67 | 0.200 |
Why?
|
| Microscopy, Confocal | 3 | 2006 | 113 | 0.200 |
Why?
|
| Adenoviruses, Human | 3 | 2010 | 23 | 0.200 |
Why?
|
| Interleukin-8 | 4 | 2018 | 45 | 0.190 |
Why?
|
| Inositol Polyphosphate 5-Phosphatases | 4 | 2010 | 6 | 0.190 |
Why?
|
| Chemokines | 4 | 2018 | 74 | 0.190 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2002 | 4 | 0.190 |
Why?
|
| Mice, Inbred BALB C | 5 | 2009 | 278 | 0.190 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 465 | 0.180 |
Why?
|
| Calcium | 9 | 2006 | 243 | 0.180 |
Why?
|
| Complement C5 | 1 | 2021 | 4 | 0.180 |
Why?
|
| Anemia, Hemolytic | 1 | 2021 | 22 | 0.180 |
Why?
|
| Lectins | 2 | 1999 | 13 | 0.170 |
Why?
|
| Acute Kidney Injury | 1 | 2021 | 74 | 0.170 |
Why?
|
| HEK293 Cells | 2 | 2012 | 202 | 0.170 |
Why?
|
| Cell Membrane | 9 | 2005 | 268 | 0.170 |
Why?
|
| Cell Adhesion Molecules | 2 | 1999 | 69 | 0.170 |
Why?
|
| Autoimmunity | 1 | 2002 | 158 | 0.160 |
Why?
|
| Antigens, CD20 | 1 | 2000 | 3 | 0.160 |
Why?
|
| Caspases | 1 | 2000 | 43 | 0.160 |
Why?
|
| Lymphoma, B-Cell | 1 | 2000 | 19 | 0.160 |
Why?
|
| RNA, Messenger | 5 | 2009 | 668 | 0.160 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 4 | 2006 | 12 | 0.160 |
Why?
|
| Brefeldin A | 1 | 2019 | 5 | 0.160 |
Why?
|
| Protein Kinase C | 7 | 1994 | 74 | 0.160 |
Why?
|
| GTP-Binding Proteins | 8 | 1996 | 46 | 0.160 |
Why?
|
| Thromboplastin | 1 | 2019 | 28 | 0.150 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2009 | 21 | 0.150 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 92 | 0.150 |
Why?
|
| Binding Sites | 5 | 2012 | 355 | 0.150 |
Why?
|
| Carrier Proteins | 4 | 2013 | 255 | 0.140 |
Why?
|
| Prekallikrein | 1 | 2018 | 2 | 0.140 |
Why?
|
| Factor XIIa | 1 | 2018 | 3 | 0.140 |
Why?
|
| Phosphatidylinositols | 5 | 1990 | 25 | 0.140 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 157 | 0.140 |
Why?
|
| Papio anubis | 1 | 2018 | 48 | 0.140 |
Why?
|
| Actins | 3 | 2012 | 99 | 0.140 |
Why?
|
| Mice, Mutant Strains | 1 | 2018 | 58 | 0.140 |
Why?
|
| Cell Line, Tumor | 4 | 2009 | 1350 | 0.140 |
Why?
|
| Protein Transport | 2 | 2011 | 158 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2009 | 251 | 0.140 |
Why?
|
| Blood Platelets | 3 | 2013 | 206 | 0.140 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 1997 | 7 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 9 | 2001 | 314 | 0.130 |
Why?
|
| Male | 5 | 2021 | 13921 | 0.130 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2002 | 109 | 0.130 |
Why?
|
| Hexokinase | 1 | 2016 | 16 | 0.130 |
Why?
|
| Lymph Nodes | 2 | 2016 | 103 | 0.120 |
Why?
|
| Inflammation | 2 | 2012 | 667 | 0.120 |
Why?
|
| Inflammasomes | 1 | 2016 | 20 | 0.120 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 1996 | 72 | 0.120 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2002 | 233 | 0.120 |
Why?
|
| Biomarkers | 1 | 2019 | 776 | 0.120 |
Why?
|
| Movement | 1 | 2016 | 100 | 0.120 |
Why?
|
| Cell Lineage | 2 | 2006 | 53 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2010 | 257 | 0.110 |
Why?
|
| Syk Kinase | 6 | 2002 | 12 | 0.110 |
Why?
|
| Blood | 2 | 2016 | 34 | 0.110 |
Why?
|
| Guanine Nucleotide Exchange Factors | 3 | 2009 | 30 | 0.110 |
Why?
|
| Phospholipase C gamma | 5 | 2002 | 13 | 0.110 |
Why?
|
| Nephritis | 1 | 2014 | 10 | 0.110 |
Why?
|
| Autoimmune Diseases | 2 | 2002 | 166 | 0.110 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 3 | 2000 | 15 | 0.110 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2005 | 59 | 0.110 |
Why?
|
| Diglycerides | 4 | 1996 | 10 | 0.110 |
Why?
|
| Complement Activation | 1 | 2014 | 27 | 0.110 |
Why?
|
| Female | 4 | 2021 | 15624 | 0.100 |
Why?
|
| COS Cells | 4 | 2006 | 49 | 0.100 |
Why?
|
| Viper Venoms | 1 | 2013 | 5 | 0.100 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2013 | 15 | 0.100 |
Why?
|
| Phosphatidylserines | 1 | 2013 | 20 | 0.100 |
Why?
|
| Gram-Positive Bacteria | 1 | 2013 | 33 | 0.100 |
Why?
|
| Plasma | 1 | 2013 | 32 | 0.100 |
Why?
|
| Immune System | 1 | 2013 | 29 | 0.100 |
Why?
|
| Shock, Septic | 1 | 2013 | 38 | 0.100 |
Why?
|
| Phosphopeptides | 3 | 1997 | 14 | 0.100 |
Why?
|
| Leukocytes | 1 | 2013 | 72 | 0.100 |
Why?
|
| Intracellular Fluid | 2 | 2011 | 12 | 0.100 |
Why?
|
| Receptors, Antigen | 2 | 2002 | 8 | 0.100 |
Why?
|
| Kinetics | 7 | 1999 | 553 | 0.100 |
Why?
|
| Histocompatibility Antigens Class II | 3 | 2009 | 61 | 0.100 |
Why?
|
| Transfection | 8 | 2001 | 319 | 0.100 |
Why?
|
| Cytoplasm | 3 | 2001 | 57 | 0.090 |
Why?
|
| Gene Expression Regulation | 4 | 2009 | 634 | 0.090 |
Why?
|
| Staphylococcal Infections | 1 | 2013 | 87 | 0.090 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 1992 | 19 | 0.090 |
Why?
|
| Cell Differentiation | 2 | 2009 | 427 | 0.090 |
Why?
|
| Adenoviridae Infections | 2 | 2010 | 10 | 0.090 |
Why?
|
| Enzyme Inhibitors | 6 | 2007 | 251 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell | 5 | 1994 | 84 | 0.090 |
Why?
|
| Sheep | 2 | 2010 | 100 | 0.090 |
Why?
|
| NFATC Transcription Factors | 2 | 2009 | 14 | 0.090 |
Why?
|
| Nod1 Signaling Adaptor Protein | 1 | 2011 | 1 | 0.090 |
Why?
|
| Acetylmuramyl-Alanyl-Isoglutamine | 1 | 2011 | 2 | 0.090 |
Why?
|
| Pneumonia, Viral | 2 | 2010 | 53 | 0.090 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2011 | 7 | 0.090 |
Why?
|
| Leukocyte Common Antigens | 2 | 2010 | 17 | 0.090 |
Why?
|
| Models, Immunological | 2 | 2002 | 22 | 0.090 |
Why?
|
| Sjogren's Syndrome | 1 | 2014 | 274 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 328 | 0.090 |
Why?
|
| Recombinant Proteins | 4 | 2000 | 416 | 0.080 |
Why?
|
| Membrane Proteins | 4 | 2012 | 485 | 0.080 |
Why?
|
| Guanosine Triphosphate | 3 | 1995 | 29 | 0.080 |
Why?
|
| Macrophages, Peritoneal | 1 | 2010 | 10 | 0.080 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2010 | 2 | 0.080 |
Why?
|
| Leukocyte Rolling | 1 | 2010 | 7 | 0.080 |
Why?
|
| Antigen-Antibody Complex | 1 | 2010 | 19 | 0.080 |
Why?
|
| E-Selectin | 1 | 2010 | 27 | 0.080 |
Why?
|
| Hyaluronan Receptors | 1 | 2010 | 31 | 0.080 |
Why?
|
| Phosphoproteins | 3 | 2000 | 120 | 0.080 |
Why?
|
| Polymers | 1 | 2011 | 117 | 0.080 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2009 | 11 | 0.080 |
Why?
|
| Aluminum Compounds | 1 | 1989 | 3 | 0.080 |
Why?
|
| Clathrin-Coated Vesicles | 1 | 2009 | 3 | 0.080 |
Why?
|
| Aluminum | 1 | 1989 | 6 | 0.080 |
Why?
|
| B7-1 Antigen | 1 | 2009 | 11 | 0.080 |
Why?
|
| Fluorides | 1 | 1989 | 10 | 0.080 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2009 | 42 | 0.080 |
Why?
|
| Culture Media, Serum-Free | 1 | 2009 | 12 | 0.080 |
Why?
|
| Antigens, CD19 | 1 | 2009 | 14 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2009 | 119 | 0.070 |
Why?
|
| Cytoskeleton | 1 | 2009 | 45 | 0.070 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2009 | 28 | 0.070 |
Why?
|
| RNA, Bacterial | 1 | 2008 | 65 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 536 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2009 | 191 | 0.070 |
Why?
|
| Influenza, Human | 1 | 2009 | 92 | 0.070 |
Why?
|
| Spleen | 2 | 2003 | 113 | 0.070 |
Why?
|
| Src Homology 2 Domain-Containing, Transforming Protein 1 | 2 | 1999 | 10 | 0.070 |
Why?
|
| Shc Signaling Adaptor Proteins | 2 | 1999 | 8 | 0.070 |
Why?
|
| CD3 Complex | 4 | 1995 | 23 | 0.070 |
Why?
|
| In Vitro Techniques | 4 | 2010 | 242 | 0.070 |
Why?
|
| Rabbits | 3 | 2001 | 277 | 0.070 |
Why?
|
| DNA, Bacterial | 1 | 2008 | 309 | 0.070 |
Why?
|
| Guanosine Diphosphate | 4 | 1994 | 18 | 0.070 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 1987 | 29 | 0.070 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 6 | 1996 | 18 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 3 | 2009 | 26 | 0.070 |
Why?
|
| Virus Internalization | 1 | 2006 | 12 | 0.060 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 3 | 1992 | 19 | 0.060 |
Why?
|
| Up-Regulation | 3 | 2018 | 247 | 0.060 |
Why?
|
| Phosphatidylinositol Phosphates | 2 | 2005 | 11 | 0.060 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2006 | 24 | 0.060 |
Why?
|
| Macromolecular Substances | 4 | 1999 | 53 | 0.060 |
Why?
|
| Inositol Phosphates | 3 | 1998 | 6 | 0.060 |
Why?
|
| Phospholipids | 2 | 1990 | 76 | 0.060 |
Why?
|
| Enzyme Induction | 2 | 2009 | 28 | 0.060 |
Why?
|
| Lymphopenia | 1 | 2005 | 8 | 0.060 |
Why?
|
| Multipotent Stem Cells | 1 | 2005 | 5 | 0.060 |
Why?
|
| Calcium Signaling | 2 | 2002 | 72 | 0.060 |
Why?
|
| Glycerides | 1 | 1985 | 1 | 0.060 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 1 | 2004 | 1 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 4 | 2003 | 336 | 0.060 |
Why?
|
| Immediate-Early Proteins | 1 | 2004 | 15 | 0.060 |
Why?
|
| Molecular Sequence Data | 7 | 1996 | 1056 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 284 | 0.050 |
Why?
|
| Neutropenia | 1 | 2004 | 41 | 0.050 |
Why?
|
| Substrate Specificity | 3 | 2000 | 151 | 0.050 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2004 | 44 | 0.050 |
Why?
|
| Epithelial Cells | 3 | 2016 | 265 | 0.050 |
Why?
|
| Cell Division | 4 | 2010 | 154 | 0.050 |
Why?
|
| CD4 Antigens | 2 | 1995 | 18 | 0.050 |
Why?
|
| Jurkat Cells | 3 | 2002 | 30 | 0.050 |
Why?
|
| Organ Culture Techniques | 2 | 2016 | 56 | 0.050 |
Why?
|
| Structure-Activity Relationship | 2 | 2002 | 209 | 0.050 |
Why?
|
| Receptors, KIR | 1 | 2002 | 3 | 0.050 |
Why?
|
| Receptors, Cytokine | 1 | 2002 | 5 | 0.050 |
Why?
|
| CD8 Antigens | 1 | 2002 | 10 | 0.050 |
Why?
|
| GPI-Linked Proteins | 1 | 2002 | 13 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2004 | 157 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2002 | 81 | 0.050 |
Why?
|
| Human T-lymphotropic virus 1 | 1 | 2002 | 4 | 0.050 |
Why?
|
| Aging | 1 | 2010 | 1016 | 0.050 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2002 | 18 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2004 | 523 | 0.050 |
Why?
|
| Granulocytes | 1 | 2002 | 6 | 0.050 |
Why?
|
| Interleukin-4 | 2 | 2000 | 23 | 0.050 |
Why?
|
| Genes | 1 | 2002 | 36 | 0.050 |
Why?
|
| Trypsin Inhibitor, Kunitz Soybean | 1 | 2001 | 1 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 3 | 1996 | 7 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1996 | 31 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2005 | 824 | 0.040 |
Why?
|
| Receptor Aggregation | 3 | 1996 | 3 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2002 | 94 | 0.040 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 2 | 1999 | 4 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2001 | 22 | 0.040 |
Why?
|
| Hemolysis | 1 | 2021 | 51 | 0.040 |
Why?
|
| Sialic Acid Binding Ig-like Lectin 2 | 2 | 1999 | 3 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2001 | 68 | 0.040 |
Why?
|
| Isoflavones | 3 | 1996 | 8 | 0.040 |
Why?
|
| Genistein | 3 | 1996 | 9 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2001 | 128 | 0.040 |
Why?
|
| Virulence | 2 | 2012 | 153 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2000 | 58 | 0.040 |
Why?
|
| Hydrolases | 1 | 2000 | 12 | 0.040 |
Why?
|
| G(M1) Ganglioside | 1 | 1999 | 3 | 0.040 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1999 | 5 | 0.040 |
Why?
|
| Amino Acid Sequence | 4 | 1996 | 697 | 0.040 |
Why?
|
| Son of Sevenless Proteins | 1 | 1998 | 1 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2013 | 515 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2002 | 481 | 0.040 |
Why?
|
| Protein Kinases | 2 | 1993 | 155 | 0.040 |
Why?
|
| Ion Transport | 1 | 1998 | 11 | 0.040 |
Why?
|
| Allosteric Regulation | 1 | 1998 | 22 | 0.040 |
Why?
|
| Platelet Factor 4 | 1 | 2018 | 5 | 0.040 |
Why?
|
| Chemokine CCL20 | 1 | 2018 | 7 | 0.040 |
Why?
|
| Chemokine CXCL5 | 1 | 2018 | 7 | 0.040 |
Why?
|
| Receptors, Interleukin-2 | 2 | 1995 | 7 | 0.040 |
Why?
|
| Glioma | 1 | 1999 | 122 | 0.040 |
Why?
|
| Naphthalenes | 2 | 1996 | 17 | 0.040 |
Why?
|
| Corpus Luteum | 1 | 1997 | 15 | 0.030 |
Why?
|
| Genes, MHC Class II | 1 | 1997 | 10 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1997 | 62 | 0.030 |
Why?
|
| Allergy and Immunology | 1 | 1997 | 5 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1994 | 31 | 0.030 |
Why?
|
| Time Factors | 1 | 2001 | 1613 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 465 | 0.030 |
Why?
|
| L-Selectin | 1 | 1996 | 11 | 0.030 |
Why?
|
| Oligopeptides | 1 | 1997 | 97 | 0.030 |
Why?
|
| Theophylline | 3 | 1986 | 6 | 0.030 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 1996 | 3 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 1996 | 3 | 0.030 |
Why?
|
| Membrane Potentials | 3 | 1987 | 65 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 1998 | 150 | 0.030 |
Why?
|
| CD40 Antigens | 1 | 1996 | 14 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2006 | 44 | 0.030 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2016 | 16 | 0.030 |
Why?
|
| Potassium | 1 | 2016 | 43 | 0.030 |
Why?
|
| Acetylation | 1 | 2016 | 41 | 0.030 |
Why?
|
| Acetylglucosamine | 1 | 2016 | 17 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 1 | 2016 | 33 | 0.030 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1996 | 27 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 1999 | 312 | 0.030 |
Why?
|
| Base Sequence | 5 | 1994 | 588 | 0.030 |
Why?
|
| Pulmonary Alveoli | 2 | 2007 | 33 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 1997 | 154 | 0.030 |
Why?
|
| Glycolysis | 1 | 2016 | 96 | 0.030 |
Why?
|
| Gene Expression | 3 | 2006 | 417 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2016 | 134 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2016 | 143 | 0.030 |
Why?
|
| Butadienes | 2 | 2007 | 14 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 1996 | 292 | 0.030 |
Why?
|
| Cattle | 3 | 2004 | 389 | 0.030 |
Why?
|
| Peptides | 2 | 1999 | 296 | 0.030 |
Why?
|
| RNA, Transfer, Met | 1 | 1994 | 1 | 0.030 |
Why?
|
| RNA, Catalytic | 1 | 1994 | 8 | 0.030 |
Why?
|
| Nitriles | 2 | 2007 | 38 | 0.030 |
Why?
|
| Plasma Cells | 1 | 2014 | 21 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2014 | 36 | 0.030 |
Why?
|
| ras Guanine Nucleotide Exchange Factors | 1 | 1994 | 1 | 0.030 |
Why?
|
| Salivary Glands | 1 | 2014 | 58 | 0.030 |
Why?
|
| Phosphotransferases | 1 | 1993 | 16 | 0.030 |
Why?
|
| Ion Channels | 2 | 1990 | 28 | 0.020 |
Why?
|
| Multigene Family | 1 | 1993 | 51 | 0.020 |
Why?
|
| Receptors, Peptide | 1 | 2012 | 20 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 2012 | 19 | 0.020 |
Why?
|
| Mitochondria | 1 | 2016 | 408 | 0.020 |
Why?
|
| Phosphatidylinositol Diacylglycerol-Lyase | 1 | 1992 | 6 | 0.020 |
Why?
|
| Immune Sera | 1 | 1992 | 22 | 0.020 |
Why?
|
| Mast Cells | 1 | 1992 | 9 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 62 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 2012 | 56 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 1992 | 19 | 0.020 |
Why?
|
| Receptors, Fc | 1 | 1992 | 31 | 0.020 |
Why?
|
| Immunoblotting | 1 | 1992 | 124 | 0.020 |
Why?
|
| Rifabutin | 3 | 1996 | 4 | 0.020 |
Why?
|
| Benzoquinones | 3 | 1996 | 26 | 0.020 |
Why?
|
| Lactams, Macrocyclic | 3 | 1996 | 26 | 0.020 |
Why?
|
| Quinones | 3 | 1996 | 23 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-hck | 1 | 2010 | 4 | 0.020 |
Why?
|
| P-Selectin | 1 | 2010 | 30 | 0.020 |
Why?
|
| Second Messenger Systems | 1 | 1990 | 13 | 0.020 |
Why?
|
| Osteoclasts | 1 | 2010 | 32 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2002 | 404 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 1990 | 39 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2010 | 39 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2009 | 18 | 0.020 |
Why?
|
| Interphase | 1 | 1989 | 6 | 0.020 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 1989 | 8 | 0.020 |
Why?
|
| Rats | 2 | 2006 | 1588 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 1989 | 30 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 1989 | 21 | 0.020 |
Why?
|
| Histocompatibility Antigens | 1 | 1989 | 8 | 0.020 |
Why?
|
| Antigens, Ly | 1 | 1989 | 9 | 0.020 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1989 | 39 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2009 | 82 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 194 | 0.020 |
Why?
|
| Bucladesine | 2 | 1986 | 11 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 150 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 513 | 0.020 |
Why?
|
| Cyclic AMP | 2 | 1987 | 96 | 0.020 |
Why?
|
| Anthracenes | 1 | 2007 | 7 | 0.020 |
Why?
|
| Receptors, Mitogen | 1 | 1987 | 1 | 0.020 |
Why?
|
| Phenotype | 1 | 1989 | 685 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1987 | 30 | 0.020 |
Why?
|
| Imidazoles | 1 | 2007 | 63 | 0.020 |
Why?
|
| Egtazic Acid | 1 | 2006 | 10 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2006 | 12 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 163 | 0.020 |
Why?
|
| Pyridines | 1 | 2007 | 108 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2006 | 63 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2006 | 153 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2006 | 68 | 0.020 |
Why?
|
| Young Adult | 1 | 2013 | 2833 | 0.010 |
Why?
|
| Fibroblasts | 2 | 1998 | 160 | 0.010 |
Why?
|
| GTPase-Activating Proteins | 2 | 1996 | 17 | 0.010 |
Why?
|
| Phospholipases | 1 | 1985 | 2 | 0.010 |
Why?
|
| Phosphatidic Acids | 1 | 1984 | 3 | 0.010 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2004 | 3 | 0.010 |
Why?
|
| STAT5 Transcription Factor | 1 | 2004 | 6 | 0.010 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2004 | 6 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1985 | 61 | 0.010 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2004 | 9 | 0.010 |
Why?
|
| Milk Proteins | 1 | 2004 | 19 | 0.010 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2004 | 18 | 0.010 |
Why?
|
| Adenovirus Infections, Human | 1 | 2004 | 8 | 0.010 |
Why?
|
| DNA Primers | 2 | 1994 | 147 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2004 | 12 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2004 | 118 | 0.010 |
Why?
|
| Muromonab-CD3 | 2 | 1994 | 7 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2004 | 119 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 2003 | 7 | 0.010 |
Why?
|
| Cloning, Molecular | 2 | 1994 | 208 | 0.010 |
Why?
|
| Cell Survival | 1 | 2004 | 419 | 0.010 |
Why?
|
| Ligands | 1 | 2003 | 178 | 0.010 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2002 | 5 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 2002 | 22 | 0.010 |
Why?
|
| Proto-Oncogenes | 2 | 1994 | 15 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 87 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2002 | 80 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 7414 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2001 | 23 | 0.010 |
Why?
|
| Epithelium | 1 | 2001 | 40 | 0.010 |
Why?
|
| Flavonoids | 1 | 2001 | 33 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 8024 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2000 | 47 | 0.010 |
Why?
|
| Genetic Therapy | 1 | 2001 | 124 | 0.010 |
Why?
|
| Immunosorbents | 1 | 1999 | 1 | 0.010 |
Why?
|
| U937 Cells | 1 | 1999 | 8 | 0.010 |
Why?
|
| Enzymes, Immobilized | 1 | 1999 | 6 | 0.010 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1999 | 21 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1998 | 89 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1998 | 258 | 0.010 |
Why?
|
| Dinoprost | 1 | 1997 | 9 | 0.010 |
Why?
|
| Mitomycin | 1 | 1997 | 19 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 1997 | 55 | 0.010 |
Why?
|
| Cell Separation | 1 | 1997 | 57 | 0.010 |
Why?
|
| Mutation | 1 | 2001 | 867 | 0.010 |
Why?
|
| Mast-Cell Sarcoma | 1 | 1996 | 1 | 0.010 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 1996 | 4 | 0.010 |
Why?
|
| Models, Molecular | 1 | 1998 | 452 | 0.010 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 1996 | 3 | 0.010 |
Why?
|
| Octoxynol | 1 | 1996 | 9 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1996 | 22 | 0.010 |
Why?
|
| Burkitt Lymphoma | 1 | 1996 | 4 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 1996 | 7 | 0.010 |
Why?
|
| Progesterone | 1 | 1997 | 130 | 0.010 |
Why?
|
| Superoxides | 1 | 1996 | 62 | 0.010 |
Why?
|
| Cyclic N-Oxides | 1 | 1996 | 26 | 0.010 |
Why?
|
| Nitrogen Oxides | 1 | 1996 | 41 | 0.010 |
Why?
|
| Solubility | 1 | 1996 | 73 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 1996 | 45 | 0.010 |
Why?
|
| Acetylcysteine | 1 | 1996 | 24 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 169 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 1996 | 123 | 0.010 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1994 | 6 | 0.010 |
Why?
|
| Neurilemmoma | 1 | 1994 | 13 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1994 | 10 | 0.010 |
Why?
|
| Antioxidants | 1 | 1996 | 224 | 0.010 |
Why?
|
| Polycyclic Compounds | 1 | 1994 | 1 | 0.010 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 1994 | 2 | 0.010 |
Why?
|
| Retroviridae | 1 | 1994 | 16 | 0.010 |
Why?
|
| Lymphoma | 1 | 1994 | 26 | 0.010 |
Why?
|
| Alkaloids | 1 | 1994 | 16 | 0.010 |
Why?
|
| Staurosporine | 1 | 1994 | 10 | 0.010 |
Why?
|
| Astrocytoma | 1 | 1994 | 37 | 0.010 |
Why?
|
| Ceramides | 1 | 1994 | 33 | 0.010 |
Why?
|
| Catalysis | 1 | 1994 | 133 | 0.010 |
Why?
|
| Point Mutation | 1 | 1994 | 61 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1994 | 132 | 0.010 |
Why?
|
| Clone Cells | 1 | 1994 | 22 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1994 | 46 | 0.010 |
Why?
|
| Oncogenes | 1 | 1994 | 34 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1994 | 118 | 0.010 |
Why?
|
| Carcinoma | 1 | 1994 | 74 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 24 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1994 | 111 | 0.010 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 1993 | 1 | 0.010 |
Why?
|
| rap GTP-Binding Proteins | 1 | 1993 | 3 | 0.010 |
Why?
|
| Melanoma | 1 | 1994 | 140 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1993 | 133 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 1993 | 83 | 0.010 |
Why?
|
| Histamine Release | 1 | 1992 | 1 | 0.010 |
Why?
|
| Receptors, IgE | 1 | 1992 | 3 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1992 | 11 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1992 | 43 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1993 | 270 | 0.010 |
Why?
|
| Cytosol | 1 | 1992 | 49 | 0.010 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1992 | 34 | 0.010 |
Why?
|
| DNA | 1 | 1993 | 377 | 0.010 |
Why?
|
| Ornithine Decarboxylase | 1 | 1990 | 9 | 0.010 |
Why?
|
| Biological Factors | 1 | 1990 | 12 | 0.000 |
Why?
|
| Polyamines | 1 | 1990 | 13 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1990 | 612 | 0.000 |
Why?
|
| Receptors, Interleukin-4 | 1 | 1987 | 2 | 0.000 |
Why?
|
| Lymphokines | 1 | 1987 | 8 | 0.000 |
Why?
|
| Growth Substances | 1 | 1987 | 11 | 0.000 |
Why?
|
| Immunoglobulin D | 1 | 1986 | 4 | 0.000 |
Why?
|
| Cell Compartmentation | 1 | 1986 | 6 | 0.000 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1986 | 16 | 0.000 |
Why?
|
| Immunoglobulin M | 1 | 1986 | 28 | 0.000 |
Why?
|